Current:Home > reviewsThis drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic -WealthSphere Pro
This drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic
View
Date:2025-04-21 13:46:11
Can we eliminate the HIV epidemic?
It's a question that dates back to the start of the epidemic in the 1980s. With 1.3 million new infections a year, the epidemic continues … and the world is not on track to meet the ambitious U.N. goal of ending HIV/AIDS by 2030.
But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking clinical trial results for a drug called lenacapavir showed it to be capable of virtually eliminating new HIV infections through sex.
The emerging data surrounding lenacapavir is so astonishing that the drug's development has been heralded as the 2024 Breakthrough of the Year by the journal Science,which described it as representing "a pivotal step toward diminishing HIV/AIDS as a global health crisis."
veryGood! (2396)
Related
- Are Instagram, Facebook and WhatsApp down? Meta says most issues resolved after outages
- Tornado-damaged Pfizer plant in North Carolina restarts production
- Pilot dies in crash of an ultralight in central New Mexico
- Pakistani raid on a militant hideout near Afghanistan leaves 3 militants dead, the military says
- Paige Bueckers vs. Hannah Hidalgo highlights women's basketball games to watch
- Milan fashion celebrated diversity and inclusion with refrain: Make more space for color, curves
- Driver pleads not guilty in Vermont crash that killed actor Treat Williams
- Journalist killed in attack aimed at police in northern Mexico border town
- Friday the 13th luck? 13 past Mega Millions jackpot wins in December. See top 10 lottery prizes
- In new effort to reset flu shot expectations, CDC to avoid messages that could be seen as a scare tactic
Ranking
- The Louvre will be renovated and the 'Mona Lisa' will have her own room
- 'Murder in Apt. 12': About Dateline's new podcast unpacking the killing of Arkansas beauty queen
- Connecticut health commissioner fired during COVID settles with state, dismissal now a resignation
- Column: Ryder Cup is in America’s head. But it’s in Europe’s blood
- The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
- 3 Top Tech Stocks That Could Help Make You Rich by Retirement
- Fantasy football sizzlers, fizzlers: De'Von Achane delivers stellar game no one saw coming
- Euphoria Star Angus Cloud's Mom Shares His Heartbreaking Last Words
Recommendation
See you latte: Starbucks plans to cut 30% of its menu
Sophie Turner, Joe Jonas reach temporary agreement over children amid lawsuit, divorce
Oregon’s top court asked to decide if GOP senators who boycotted Legislature can be reelected
The latest Apple Watches are coming to stores Friday, here's what to know
San Francisco names street for Associated Press photographer who captured the iconic Iwo Jima photo
A Drop in Emissions, and a Jobs Bonanza? Critics Question Benefits of a Proposed Hydrogen Hub for the Appalachian Region
Court appointee proposes Alabama congressional districts to provide representation to Black voters
A Swiftie's guide to Travis Kelce: What to know about Kansas City Chiefs tight end